title: [Case of osteomalacia due to intravenous saccharated ferric oxide].
authors.forename: T
authors.initials: T
authors.lastname: Nakaoka
authors.forename: T
authors.initials: T
authors.lastname: Sugimoto
authors.forename: Y
authors.initials: Y
authors.lastname: Okimura
authors.forename: K
authors.initials: K
authors.lastname: Chihara
mesh_terms: D000368:Aged; D000469:Alkaline Phosphatase / Q000378:metabolism; D015519:Bone Density; D005260:Female; D005290:Ferric Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D005293:Ferritins / Q000378:metabolism; D006801:Humans; D007262:Infusions, Intravenous; D010018:Osteomalacia / Q000139:chemically induced* / Q000378:metabolism / Q000503:physiopathology; D010758:Phosphorus / Q000378:metabolism
chemical_list: D005290:Ferric Compounds; C000499:ferric oxide; D010758:Phosphorus; D005293:Ferritins; D000469:Alkaline Phosphatase